GSK

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.05
Percentage change 0.14	%

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: FVD AVDE PPH FENI RODM DFAX AVIV BINV APIE FFLC

Scroll to Statements

Index	-	P/E	19.79	EPS (ttm)	1.93	Insider Own	0.00%	Shs Outstand	2.04B	Perf Week	-6.69%
Market Cap	77.21B	Forward P/E	7.73	EPS next Y	4.93	Insider Trans	-	Shs Float	2.03B	Perf Month	-1.08%
Enterprise Value	94.56B	PEG	2.01	EPS next Q	1.16	Inst Own	18.14%	Short Float	0.82%	Perf Quarter	-2.84%
Income	3.98B	P/S	1.92	EPS this Y	10.64%	Inst Trans	-5.20%	Short Ratio	3.03	Perf Half Y	11.38%
Sales	40.23B	P/B	4.26	EPS next Y	11.84%	ROA	5.23%	Short Interest	16.67M	Perf YTD	12.73%
Book/sh	8.95	P/C	13.34	EPS next 5Y	9.83%	ROE	22.26%	52W High	44.67 -14.65%	Perf Year	-6.90%
Cash/sh	2.86	P/FCF	12.18	EPS past 3/5Y	-24.61% -11.63%	ROIC	10.07%	52W Low	31.72 20.21%	Perf 3Y	-10.73%
Dividend Est.	1.75 (4.60%)	EV/EBITDA	8.29	Sales past 3/5Y	5.68% -1.42%	Gross Margin	71.84%	Volatility	0.78% 1.85%	Perf 5Y	-9.36%
Dividend TTM	1.61 (4.21%)	EV/Sales	2.35	EPS Y/Y TTM	-29.96%	Oper. Margin	18.02%	ATR (14)	0.82	Perf 10Y	-9.88%
Dividend Ex-Date	May 16, 2025	Quick Ratio	0.58	Sales Y/Y TTM	4.17%	Profit Margin	9.89%	RSI (14)	40.69	Recom	3.00
Dividend Gr. 3/5Y	-16.94% -9.13%	Current Ratio	0.87	EPS Q/Q	53.31%	SMA20	-5.37%	Beta	0.52	Target Price	44.23
Payout	94.89%	Debt/Eq	1.30	Sales Q/Q	1.38%	SMA50	-0.82%	Rel Volume	0.73	Prev Close	38.07
Employees	68629	LT Debt/Eq	1.16	Earnings	Apr 30 BMO	SMA200	1.91%	Avg Volume	5.49M	Price	38.12
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.83% 3.33%	Trades		Volume	3,300,667	Change	0.14%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral

Show Previous Ratings

Today 09:53AM	FDA Extends INCY's Application for Opzelura Label Expansion (Zacks)
09:40AM	GSK (GSK) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jun-19-25 01:30PM	FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention (Zacks)
Jun-18-25 08:57PM	Analyst Report: GSK plc (Morningstar Research)
10:22AM	GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold? (Zacks)
10:00AM	Loading…
10:00AM	Trump administration weighs crackdown on pharma ads, Bloomberg says (TipRanks)
Jun-17-25 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Jun-16-25 11:20AM	EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy (Zacks)
09:40AM	Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year? (Zacks)
09:40AM	Is Central Japan Railway Co. (CJPRY) Stock Outpacing Its Transportation Peers This Year? (Zacks)
09:40AM	Is EPR Properties (EPR) Stock Outpacing Its Finance Peers This Year? (Zacks)
09:40AM	Is Adyen (ADYEY) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
09:40AM	Are Consumer Discretionary Stocks Lagging Accel Entertainment (ACEL) This Year? (Zacks)
09:40AM	Are Construction Stocks Lagging EMCOR Group (EME) This Year? (Zacks)
09:40AM	Loading…
09:40AM	Is AppLovin (APP) Stock Outpacing Its Business Services Peers This Year? (Zacks)
09:40AM	Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? (Zacks)
09:33AM	GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US (Business Wire)
Jun-13-25 12:45PM	Senators to propose ban on drug ads to consumers, WSJ reports (TipRanks)
Jun-12-25 08:45PM	Analyst Report: GSK plc (Morningstar Research)
Jun-11-25 10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
09:47AM	FDA Places Clinical Hold on Gilead's HIV Studies, Stock Down (Zacks)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
Jun-09-25 06:07PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
Jun-07-25 05:59AM	Patents and economies of scale support Pfizer's wide moat (GuruFocus.com)
Jun-06-25 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Jun-05-25 11:31AM	Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-03-25 11:53AM	TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises (Zacks)
11:41AM	FDA Accepts GSK's NDA for Linerixibat in Rare Disease-Related Itch (Zacks)
09:10AM	Loading…
09:10AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
07:59AM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
Jun-02-25 06:00AM	Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million (PR Newswire)
May-30-25 11:31AM	Glaxo (GSK) Up 3.2% Since Last Earnings Report: Can It Continue? (Zacks)
11:09AM	Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold? (Zacks)
10:00AM	Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates (Zacks)
May-29-25 06:35PM	CEOs Weigh in on Tariffs, the Economy at WSJs Future of Everything (The Wall Street Journal)
01:42PM	United Airlines CEO Talks Safety and Race to Fix Air-Traffic Control (The Wall Street Journal)
11:18AM	SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal (Zacks)
09:40AM	Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? (Zacks)
07:10AM	Buy 5 High Dividend-Paying Giants to Stay Safe Amid Volatile Markets (Zacks)
06:20AM	Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? (Zacks)
May-28-25 01:33PM	GSK CEO Says Drugmaker Can Navigate Potential New U.S. Tariffs (The Wall Street Journal)
11:54AM	From Autos to Pharma, CEOs Navigate Tariff Impacts (The Wall Street Journal)
07:00AM	Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee (GlobeNewswire)
May-27-25 09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
May-26-25 11:44AM	GSK Gets CHMP Nod for Blenrep Combos in Multiple Myeloma (Zacks)
May-23-25 06:19AM	FDA Approves GSK's Nucala for Expanded Use in COPD (Zacks)
02:30AM	GSK plc (GSK)'s Asthma Drug Gets FDA Nod to Treat 'Smoker's Lung' (Insider Monkey)
May-22-25 04:15PM	Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD) (Business Wire)
May-21-25 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
09:10AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
06:59AM	ATS 2025: GSK strengthens argument for twice-annual depemokimab (Pharmaceutical Technology)
May-20-25 12:56PM	Gilead Sciences vs GSK: Which HIV Drugmaker is a Smarter Buy Now? (Zacks)
08:58AM	Ionis' Tryngolza Cuts Triglyceride Levels in Late-Stage Study (Zacks)
May-19-25 11:40AM	GSK or ACAD: Which Is the Better Value Stock Right Now? (Zacks)
11:10AM	Why These 4 Women-Run Companies Deserve a Spot in Your Portfolio? (Zacks)
09:51AM	The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie (Zacks)
02:41AM	GSKs Blood-Cancer Treatment Combinations Approved in Japan (The Wall Street Journal)
May-16-25 08:06AM	Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals (Zacks)
May-15-25 11:20AM	New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel (The Wall Street Journal)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
07:55AM	GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug (Zacks)
May-14-25 06:53AM	GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion (The Wall Street Journal)
03:01AM	GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q4 2025 Earnings Call Highlights: Strong ... (GuruFocus.com)
May-13-25 04:56PM	Is GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? (Insider Monkey)
12:35PM	iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile (Benzinga)
May-12-25 12:00PM	Glaxo (GSK) Upgraded to Buy: Here's What You Should Know (Zacks)
07:33AM	Trumps Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks (The Wall Street Journal)
04:28AM	Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices (Bloomberg)
03:39AM	Trump's Plan to Cut Drug Prices Hits Pharma Stocks (The Wall Street Journal)
May-09-25 12:39PM	Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y (Zacks)
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
09:00AM	GSK and Lifetime launch original movie to raise awareness about the impact of meningitis (Business Wire)
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
May-06-25 09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)
May-05-25 11:37AM	5 Reasons GSK Looks Good (Seeking Alpha)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
03:04AM	European Firms Fare Better Than Feared Through Early Trade Pain (Bloomberg)
May-01-25 11:22AM	Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts (Zacks)
11:01AM	GSK PLC (GSK) Q1 2025 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ... (GuruFocus.com)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
06:46AM	Analyst Report: GSK plc (Morningstar Research)
12:47AM	US risks recession as economy shrinks in tariff war (The Telegraph)
Apr-30-25 04:27PM	GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs (Investor's Business Daily)
12:32PM	GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha)
11:45AM	GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance (Zacks)
11:05AM	Tariff turmoil prompts cloudy forecasts from companies for the year ahead (Associated Press Finance)
09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
09:09AM	Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss? (Zacks)
08:51AM	GSK Posts Strong Results, Says 'Well Positioned' in Case of Pharma Tariffs (Investopedia)
07:05AM	GSK (GSK) Q1 Earnings Surpass Estimates (Zacks)
03:07AM	GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs (The Wall Street Journal)
Apr-29-25 03:46PM	SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO (Seeking Alpha)
Apr-28-25 09:14AM	GSK to Report First-Quarter Earnings: Is a Beat in Store? (Zacks)
Apr-25-25 04:30PM	Is GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now? (Insider Monkey)
10:41AM	GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline (Zacks)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Apr-24-25 10:01AM	Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline (Zacks)
Apr-23-25 05:48PM	Shingles Vaccine Appears to Lower Dementia Risk (The Wall Street Journal)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK Plc ADR

Upgrade your FINVIZ experience